A first-in-human study of (D)-18F-fluoromethyltyrosine (D-18F-FMT), a tyrosine derivative, is being evaluated for diagnostic imaging of non-small cell lung cancer (NSCLC) as well as head and neck squamous cell cancers (HNSCC). Results show that it could provide some differentiation in a space dominated by FDG, according to a study published Sept. 25 in the Journal of Nuclear Medicine . {read more here}